CD79A and infection: Overall, our data emphasize that three times vaccinated individuals, who received the bivalent booster, as well as SARS-COV-2-vaccinated individuals following natural infection with the Omicron subvariants BA.4 or BA.5, show comparable serum and salivary IgA values and neutralization capacities against the new sublineages of SARS-CoV-2.